LRFN3

LRFN3 (SALM4) is a brain-enriched synaptic adhesion molecule with LRR-Ig-Fn-transmembrane architecture that lacks a PDZ-binding domain and functions as a negative regulator of excitatory synapse development and NMDA receptor signaling. LRFN3 suppresses excitatory synaptogenesis by cis-interacting with SALM3, thereby blocking SALM3's trans-synaptic engagement of presynaptic LAR-family receptor tyrosine phosphatases; Lrfn3-knockout mice exhibit increased hippocampal excitatory synapse numbers that are normalized by concurrent Salm3 deletion (PMID:27480238). LRFN3 also restrains GluN2B-containing NMDA receptor currents through a presynaptic PTPσ-dependent mechanism, and its loss enhances contextual fear memory consolidation (PMID:34588597). During early neuronal development, LRFN3 promotes neurite branching via a flotillin-1/lipid raft/actin/exocyst signaling pathway (PMID:20600927).

1. 2006 Medium

   Establishing the SALM/LRFN family as synaptic adhesion molecules and identifying that LRFN3 uniquely lacks a PDZ-binding domain and does not bind PSD-95, distinguishing it from other family members.

   Evidence Sequence analysis, expression profiling, and heterologous cell co-expression with PSD-95 for LRFN3; co-immunoprecipitation from brain for SALM1

   PMID:16495444 PMID:16828986

   Open questions at the time

   • No direct interactors identified for LRFN3 itself at this stage
   • Functional consequence of lacking PSD-95 binding not determined
   • LRFN3-specific postsynaptic roles not addressed
2. 2010 Medium

   Demonstrating that LRFN3 has an active neurodevelopmental function — promoting neurite branching — and delineating the flotillin-1/lipid raft/actin/exocyst pathway that mediates this effect.

   Evidence siRNA knockdown and overexpression in cultured hippocampal neurons with domain-deletion constructs and lipid raft disruption

   PMID:20600927

   Open questions at the time

   • In vivo relevance of neurite branching phenotype not tested
   • Direct physical interaction between LRFN3 and flotillin-1 not shown by reciprocal pull-down
   • Whether this pathway operates independently of synaptic adhesion functions unknown
3. 2011 Medium

   Revealing that LRFN3 engages in homophilic trans-cellular adhesion rather than heteromeric cis-complexes with SALM1-3, suggesting a distinct adhesion mode.

   Evidence Cell-based adhesion assays and co-immunoprecipitation

   PMID:21736948

   Open questions at the time

   • Data drawn partly from a review synthesis rather than a single primary study
   • Structural basis of homophilic adhesion not resolved
   • Physiological relevance of homophilic adhesion in vivo unknown
4. 2016 High

   Establishing LRFN3 as a negative regulator of excitatory synaptogenesis through a cis-inhibition mechanism: LRFN3 directly binds SALM3 in cis to block its trans-synaptic interaction with LAR-family phosphatases, and genetic epistasis in double-knockout mice confirmed this pathway.

   Evidence Reciprocal co-immunoprecipitation for cis-interaction; Salm4-knockout and Salm3;Salm4 double-knockout mice with hippocampal synapse quantification

   PMID:27480238

   Open questions at the time

   • Structural interface mediating LRFN3–SALM3 cis-interaction not mapped
   • Whether LRFN3 cis-inhibits other SALM family members not tested
   • Behavioral consequences of altered excitatory synapse number in Salm4-knockout mice not reported here
5. 2021 High

   Extending LRFN3's inhibitory role to NMDA receptor function: LRFN3 suppresses GluN2B-NMDAR currents via a presynaptic PTPσ-dependent mechanism and limits fear memory consolidation, linking synaptic adhesion to receptor-level and behavioral regulation.

   Evidence Lrfn3-knockout mice; hippocampal electrophysiology (NMDAR/AMPAR currents); contextual fear conditioning; pharmacological rescue with fluoxetine and ifenprodil

   PMID:34588597

   Open questions at the time

   • Molecular mechanism by which LRFN3–PTPσ trans-synaptic signaling regulates GluN2B surface expression or gating not defined
   • Whether LRFN3-mediated NMDAR suppression is independent of the SALM3 cis-inhibition pathway unclear
   • Whether LRFN3's homophilic trans-adhesion contributes to NMDAR regulation not addressed

• Key unresolved questions include the structural basis of LRFN3–SALM3 cis-interaction and LRFN3 homophilic trans-adhesion, whether the neurite branching and synapse-suppressive functions are mechanistically linked, and how LRFN3's multiple signaling modes (cis-inhibition, NMDAR regulation, flotillin-1 pathway) are coordinated in vivo.
• No crystal or cryo-EM structure for LRFN3 or its complexes
• Relationship between flotillin-1-dependent neurite branching and synapse suppression untested
• Human genetic studies linking LRFN3 variants to neuropsychiatric phenotypes lacking